Medicine and Dentistry
Abdominal Cancer
33%
Adenocarcinoma
21%
Adjuvant Chemotherapy
12%
Adjuvant Therapy
21%
Adrenal Cortex Carcinoma
15%
Adrenalectomy
6%
Base
11%
Bleeding
8%
Blood Transfusion
7%
Body Mass Index
6%
Breast Cancer
15%
Cancer
50%
Cancer Cell
7%
Cancer Staging
7%
Cancer Surgery
16%
Chemoradiotherapy
11%
Cholangiocarcinoma
74%
Clinical Trial
7%
Clinician
7%
Colectomy
8%
Colon Carcinoma
6%
Colorectal Carcinoma
17%
Comorbidity
6%
Connective Tissue Cancer
6%
Cost-Effectiveness Analysis
6%
Cross Sectional Study
6%
Cytoreductive Surgery
12%
Disease Free Survival
9%
Disease Specific Survival
8%
Diseases
62%
Distal Pancreatectomy
9%
Esophageal Cancer
6%
Gallbladder Cancer
20%
Gastrectomy
6%
Gastrointestinal Stromal Tumor
11%
General Surgery
13%
Hazard Ratio
24%
Health Care
6%
Health Care Cost
23%
Hepatectomy
44%
Hepatocellular Carcinoma
14%
Hyperthermic Intraperitoneal Chemotherapy
9%
Liver Metastasis
17%
Liver Tumor
7%
Logistic Regression Analysis
11%
Long Term Survival
12%
Lung Cancer
6%
Lymph Node
38%
Lymph Node Metastasis
21%
Lymphocyte
6%
Lymphovascular Invasion
7%
Magnetic Resonance Imaging
6%
Malignant Neoplasm
61%
Medicare
9%
Melanoma
24%
Metastatic Carcinoma
27%
Minimally Invasive Procedure
6%
Multivariate Analysis
11%
Neck
12%
Neoadjuvant Chemotherapy
11%
Neoadjuvant Therapy
16%
Neoplasm
100%
Neuroendocrine Tumor
19%
Odds Ratio
35%
Oncologist
12%
Overall Survival
73%
Pancreas Adenocarcinoma
30%
Pancreas Cancer
38%
Pancreas Fistula
7%
Pancreas Islet Cell Tumor
26%
Pancreatectomy
13%
Pancreaticoduodenectomy
28%
Patient-Reported Outcome
6%
Pediatrics
12%
Postoperative Complication
25%
Primary Health Care
10%
Primary Tumor
8%
Prognostic Factor
7%
Proportional Hazards Model
8%
Quality Improvement
36%
Quality of Life
7%
Radiation Therapy
8%
Radiofrequency Ablation
6%
Recurrence Free Survival
25%
Recurrent Disease
50%
Reoperation
8%
Retroperitoneal Lymph Node Dissection
23%
Sentinel Lymph Node Biopsy
10%
Soft Tissue Sarcoma
9%
Stomach Adenocarcinoma
20%
Surgeon
52%
Surgical Infection
11%
Surgical Margin
10%
Surgical Technique
6%
Survival Rate
7%
Symptomatic Treatment
7%
Systemic Therapy
6%
Thyroid Cancer
8%
Thyroidectomy
9%
Venous Thromboembolism
12%
Keyphrases
30-day Mortality
8%
5-year Survival
15%
Adenocarcinoma
8%
Adjuvant Chemotherapy
12%
Adjuvant Therapy
23%
Adrenocortical Carcinoma
15%
After Surgery
9%
American College of Surgeons
7%
American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)
20%
Biliary Malignancy
13%
Breast Cancer
9%
Cancer Care
8%
Chemotherapy
15%
Chicago
10%
Colorectal Cancer
12%
Confidence Interval
36%
Curative Intent
10%
Curative Resection
32%
Cytoreductive Surgery
11%
Disease-free Survival
10%
Disease-specific Survival
9%
Duty Hours
9%
Early Recurrence
10%
Gallbladder Cancer
21%
Gastric Adenocarcinoma
17%
Gastric Cancer
27%
Gastrointestinal Stromal Tumor
9%
General Practitioners
10%
General Surgery
8%
General Surgery Residents
9%
Hazard Ratio
26%
Hepatectomy
8%
Hepatic Resection
11%
Hepatocellular Carcinoma
12%
High Risk
12%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
13%
Improved Survival
8%
Intrahepatic Cholangiocarcinoma (iCCA)
49%
Length of Stay
10%
Liver
10%
Liver Resection
13%
Long-term Survival
12%
Lymph Node
14%
Lymph Node Metastasis
22%
Lymphadenectomy
10%
Major Hepatectomy
8%
Malignancy
11%
Melanoma
22%
Metastatic Disease
9%
Multi-institutional
14%
Multi-institutional Analysis
25%
Multi-institutional Database
8%
Multi-institutional Study
11%
Multivariable
13%
Multivariate Analysis
11%
National Cancer Database
21%
National Surgical Quality Improvement Program (NSQIP)
8%
Neoadjuvant Chemotherapy
12%
Neoadjuvant Therapy
16%
Neuroendocrine Tumor
12%
Neuroendocrine Tumor Liver Metastases
8%
Nomogram
8%
Non-associated
12%
Odds Ratio
36%
Operative
9%
Overall Survival
59%
Pancreas
12%
Pancreatectomy
9%
Pancreatic Adenocarcinoma
19%
Pancreatic Cancer
31%
Pancreatic Ductal Adenocarcinoma
14%
Pancreatic Neuroendocrine Tumors (pNETs)
22%
Pancreaticoduodenectomy
27%
Patient Characteristics
9%
Patient Selection
10%
Peritoneal Surface Malignancy
10%
Postoperative Complications
21%
Postoperative Mortality
9%
Postoperative Outcomes
20%
Primary Care
12%
Quality Measures
11%
Radiofrequency Ablation
10%
Readmission
15%
Recurrence-free Survival
25%
Resectable Pancreatic Cancer
9%
Resection
88%
Risk Factors
15%
Sentinel Lymph Node Biopsy
12%
Single Institution
11%
Surgeons
28%
Surgical Management
11%
Surgical Outcomes
12%
Surgical Resection
17%
Surgical Site Infection
9%
Survival Benefit
8%
Treatment Strategy
9%
Tumor
39%
Tumor Size
18%
United States
40%
Venous Thromboembolism
12%